Health
Could synNotch CAR T cells be the answer to fighting solid tumours? – Drug Target Review
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
Posted: 22 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
A novel chimeric antigen receptor T-cell (CAR T) therapy targeting neuroblastoma effectively killed cancer cells while sparing healthy tissues in pre-clinical studies. While this work is in the preclinical phase, the developers of the treatment said it opens the door for other potentially…
-
Noosa News9 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business14 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business12 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025